{"id":"https://openalex.org/W2076357587","doi":"https://doi.org/10.1002/syn.890090309","title":"Effects of CI\u2010943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations","display_name":"Effects of CI\u2010943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations","publication_year":1991,"publication_date":"1991-11-01","ids":{"openalex":"https://openalex.org/W2076357587","doi":"https://doi.org/10.1002/syn.890090309","mag":"2076357587","pmid":"https://pubmed.ncbi.nlm.nih.gov/1685600"},"language":"en","primary_location":{"id":"doi:10.1002/syn.890090309","doi":"https://doi.org/10.1002/syn.890090309","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890090309","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069522699","display_name":"Beth Levant","orcid":"https://orcid.org/0000-0002-8143-9220","observed_orcids":["https://orcid.org/0000-0002-8143-9220"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Beth Levant","raw_affiliation_strings":["Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710","Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087243297","display_name":"Garth Bissette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garth Bissette","raw_affiliation_strings":["Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710","Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020273928","display_name":"Michael Duff Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Duff Davis","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109972212","display_name":"Thomas G. Heffner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas G. Heffner","raw_affiliation_strings":["Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105","Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105","institution_ids":[]},{"raw_affiliation_string":"Pfizer","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050356892","display_name":"Charles B. Nemeroff","orcid":"https://orcid.org/0000-0001-7867-1160","observed_orcids":["https://orcid.org/0000-0001-7867-1160"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Charles B. Nemeroff","raw_affiliation_strings":["Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710","Duke University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710","institution_ids":["https://openalex.org/I4210126298"]},{"raw_affiliation_string":"Duke University","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5050356892"],"corresponding_institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"],"apc_list":{"value":3570,"currency":"USD","value_usd":3570},"apc_paid":null,"fwci":0.6535,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.63662642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"3","first_page":"225","last_page":"230"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.4377000033855438,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.4377000033855438,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.38600000739097595,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.15029999613761902,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9869999885559082},{"id":"https://openalex.org/keywords/neurotensin","display_name":"neurotensin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nucleus-accumbens","display_name":"nucleus accumbens","score":0.9179999828338623},{"id":"https://openalex.org/keywords/caudate-nucleus","display_name":"caudate nucleus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/substantia-nigra-ventral-tegmental-area","display_name":"substantia nigra/ventral tegmental area","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hypothalamus","display_name":"hypothalamus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-drug-administration","display_name":"chronic drug administration","score":0.7089999914169312},{"id":"https://openalex.org/keywords/methamphetamine","display_name":"methamphetamine","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.900885283946991},{"id":"https://openalex.org/C2778976297","wikidata":"https://www.wikidata.org/wiki/Q419576","display_name":"Neurotensin","level":4,"score":0.8845975399017334},{"id":"https://openalex.org/C3019878999","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic drug","level":4,"score":0.7141404151916504},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6367658972740173},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.602440357208252},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.54509437084198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42310231924057007},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3417772948741913},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2926276922225952},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.29063549637794495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2523959279060364},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.20874780416488647},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.11790710687637329},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1155707836151123}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009496","descriptor_name":"Neurotensin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009994","descriptor_name":"Osmolar Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/syn.890090309","doi":"https://doi.org/10.1002/syn.890090309","is_oa":false,"landing_page_url":"https://doi.org/10.1002/syn.890090309","pdf_url":null,"source":{"id":"https://openalex.org/S158211696","display_name":"Synapse","issn_l":"0887-4476","issn":["0887-4476","1098-2396"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse","raw_type":"journal-article"},{"id":"pmid:1685600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1685600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Synapse (New York, N.Y.)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8299999833106995,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2376391834","display_name":null,"funder_award_id":"MH39415","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1684853394","https://openalex.org/W1775749144","https://openalex.org/W1844140394","https://openalex.org/W1905940192","https://openalex.org/W1986731927","https://openalex.org/W2027675670","https://openalex.org/W2044449613","https://openalex.org/W2062921045","https://openalex.org/W2064802845","https://openalex.org/W2067678628","https://openalex.org/W2071167726","https://openalex.org/W2074558407","https://openalex.org/W2080627371","https://openalex.org/W2094389331","https://openalex.org/W2105009993","https://openalex.org/W2145007713","https://openalex.org/W2229755816","https://openalex.org/W2259090185","https://openalex.org/W2271278384","https://openalex.org/W2288497293","https://openalex.org/W2399505584","https://openalex.org/W2412330035"],"related_works":["https://openalex.org/W1979968471","https://openalex.org/W2064802845","https://openalex.org/W2067678628","https://openalex.org/W2133241551","https://openalex.org/W2237949657","https://openalex.org/W2399505584","https://openalex.org/W2030568989","https://openalex.org/W2121293946","https://openalex.org/W2158905380","https://openalex.org/W2029603533"],"abstract_inverted_index":{"Treatment":[0],"with":[1,32,74,167,181],"efficacious":[2],"antipsychotic":[3,62],"drugs":[4],"such":[5],"as":[6],"haloperidol":[7,77,142],"increases":[8,25,91,134],"the":[9,15,22,33,67,93,98,107,121,139,149,160],"concentrations":[10,28,82,94,119],"of":[11,21,38,69,95,159,184],"neurotensin":[12],"(NT)":[13],"in":[14,26,54,83,92,97,106,120,128,135,138,148],"nucleus":[16,20,99,103,122],"accumbens":[17,100,123],"and":[18,101,124,143,154],"caudate":[19,102,125,140],"rat.":[23],"These":[24],"NT":[27,81,96,118,136,146,161],"may":[29,60],"be":[30],"associated":[31],"therapeutic":[34],"and/or":[35],"side":[36],"effects":[37,53,68],"these":[39],"drugs.":[40],"CI-943,":[41,168],"a":[42,169],"novel":[43],"compound":[44],"without":[45],"appreciable":[46],"affinity":[47],"for":[48],"dopamine-binding":[49],"sites,":[50],"produces":[51],"behavioral":[52],"animals,":[55],"which":[56],"suggest":[57],"that":[58,129,176],"it":[59],"possess":[61],"activity.":[63],"This":[64],"study":[65],"evaluated":[66],"subchronic":[70],"treatment":[71,86,166,180],"(3":[72],"weeks)":[73],"CI-943":[75,114,130],"or":[76],"on":[78],"regional":[79,157],"brain":[80,109],"rats.":[84],"Haloperidol":[85],"(1":[87],"mg/kg)":[88,116],"produced":[89,131,163],"significant":[90],"but":[104,126],"not":[105],"other":[108],"regions":[110],"studied.":[111],"Like":[112],"haloperidol,":[113],"(40":[115],"increased":[117,145],"differed":[127],"significantly":[132],"greater":[133],"concentration":[137],"than":[141],"also":[144],"content":[147],"substantia":[150],"nigra/ventral":[151],"tegmental":[152],"area":[153],"hypothalamus.":[155],"The":[156],"specificity":[158],"alterations":[162],"by":[164],"chronic":[165],"nondopamine":[170],"receptor":[171],"ligand,":[172],"was":[173],"similar":[174],"to":[175],"previously":[177],"reported":[178],"after":[179],"multiple":[182],"doses":[183],"methamphetamine.":[185]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}